Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices.

Journal of Cardiovascular Translational Research
Jennifer M Singelyn, Karen L Christman

Abstract

Cardiovascular disease continues to be the leading cause of death, suggesting that new therapies are needed to treat the progression of heart failure post-myocardial infarction. As cardiac tissue has a limited ability to regenerate itself, experimental biomaterial therapies have focused on the replacement of necrotic cardiomyocytes and repair of the damaged extracellular matrix. While acellular and cellular cardiac patches are applied surgically to the epicardial surface of the heart, injectable materials offer the prospective advantage of minimally invasive delivery directly into the myocardium to either replace the damaged extracellular matrix or to act as a scaffold for cell delivery. Cardiac-specific decellularized matrices offer the further advantage of being biomimetic of the native biochemical and structural matrix composition, as well as the potential to be autologous therapies. This review will focus on the requirements of an ideal scaffold for catheter-based delivery as well as highlight the promise of decellularized matrices as injectable materials for cardiac repair.

References

Jun 1, 1978·The American Journal of Cardiology·G M Hutchins, B H Bulkley
Sep 1, 1992·The Journal of Pathology·W D ThompsonA Kocchar
Sep 9, 1992·International Journal of Cancer. Journal International Du Cancer·A AlbiniR Gavazzi
Jul 1, 1988·Circulation·H F WeismanB Healy
May 1, 1987·Journal of the American College of Cardiology·R W JeremyP J Harris
Aug 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·C M DuranR Martin-Duran
Mar 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·W Yue, A Brodie
Oct 17, 1996·The New England Journal of Medicine·J NarulaB A Khaw
Nov 17, 2001·Chemical Reviews·K Y Lee, D J Mooney
Jul 5, 2002·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Nabil DibDoris A Taylor
Apr 12, 2003·Pacing and Clinical Electrophysiology : PACE·Valeri ChekanovNicholas N Kipshidze
Apr 18, 2003·Biomaterials·Eugene Khor, Lee Yong Lim
Apr 30, 2003·The Heart Surgery Forum·Stephen BadylakRobert Matheny
Jun 12, 2003·Journal of the American College of Cardiology·Craig A ThompsonStephen N Oesterle
Jul 17, 2004·Journal of Biomaterials Science. Polymer Edition·Zarana S Patel, Antonios G Mikos
Oct 1, 2004·The Journal of Thoracic and Cardiovascular Surgery·Theo KofidisRobert C Robbins
Jan 27, 2005·Pharmacology & Therapeutics·Jonathan LeorSmadar Cohen
Apr 19, 2005·Journal of Neural Transmission·J H Wolf, P Foley
Jul 9, 2005·Circulation Research·Michael E DavisRichard T Lee
Aug 16, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Lindsay Brown
Sep 15, 2005·Circulation·Keith A RobinsonStephen F Badylak
Dec 17, 2005·The Journal of Clinical Investigation·Patrick C H HsiehRichard T Lee
Jan 13, 2006·Circulation·Thomas ThomUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jan 18, 2006·Tissue Engineering·Ngan F HuangRandall J Lee
Jan 26, 2006·Artificial Organs·Pingchuan ZhangShengshou Hu
Feb 7, 2006·Journal of Pharmacological and Toxicological Methods·Nabil DibShaun R Opie
Mar 8, 2006·Biomaterials·Thomas W GilbertStephen F Badylak
May 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Michael E DavisRichard T Lee

❮ Previous
Next ❯

Citations

Feb 3, 2011·Journal of Materials Science. Materials in Medicine·Daniel EberliJames J Yoo
Jun 23, 2011·Journal of Cardiovascular Translational Research·Sonya B Seif-NaraghiKaren L Christman
Jul 13, 2011·Journal of Cardiovascular Translational Research·Sara S NunesMilica Radisic
Nov 18, 2011·Journal of Cardiovascular Translational Research·Jay H Traverse
Nov 22, 2011·Nanotechnology·Todd D JohnsonKaren L Christman
Aug 22, 2013·Tissue Engineering. Part a·Shawn P GroganDarryl D D'Lima
Dec 29, 2012·International Journal of Nanomedicine·Rajeswari RavichandranSeeram Ramakrishna
Oct 2, 2013·BioMed Research International·Nanako KawaguchiToshio Nakanishi
May 14, 2014·International Journal of Cardiology·Cristina Prat-VidalAntoni Bayes-Genis
Jan 18, 2014·Tissue Engineering. Part a·Seokwon PokJeffrey G Jacot
Oct 19, 2011·Stem Cell Reviews and Reports·Giancarlo ForteTakao Aoyagi
Feb 19, 2016·Biomaterials·Joseph M Aamodt, David W Grainger
May 6, 2011·Expert Opinion on Biological Therapy·Udi Sarig, Marcelle Machluf
Feb 11, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·S Pascual-GilM J Blanco-Prieto
Aug 31, 2014·Advanced Drug Delivery Reviews·Conn L HastingsGarry P Duffy
Feb 1, 2011·Advanced Drug Delivery Reviews·C V C BoutenF P T Baaijens
Oct 15, 2013·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·David A DunnElizabeth A Lipke
Sep 24, 2015·Stem Cell Research & Therapy·Jozef BartunekAtta Behfar
Jun 30, 2015·Journal of Cellular and Molecular Medicine·Cheng-Han ChenReza Ardehali
Jan 11, 2014·Biotechnology Advances·Janani RadhakrishnanSwaminathan Sethuraman
Jul 25, 2015·Stem Cell Research & Therapy·Carolina Gálvez-MontónAntoni Bayes-Genis
Aug 25, 2015·Stem Cells International·J-F StoltzY He
May 26, 2015·Biomaterials·Pedro L SánchezFrancisco Fernández-Avilés
Aug 7, 2012·Cell Adhesion & Migration·Cheng-han YuMichael P Sheetz
Dec 14, 2011·Journal of the American College of Cardiology·Aboli A Rane, Karen L Christman
Mar 6, 2012·Cell Stem Cell·Sudhir H RanganathJeffrey M Karp
Oct 30, 2016·Clinical Hemorheology and Microcirculation·J-F StoltzL Reppel
Dec 15, 2016·Biomacromolecules·Janani RadhakrishnanSwaminathan Sethuraman
Mar 10, 2017·Journal of Biomaterials Science. Polymer Edition·Farinaz KetabatSeyed Hossein Ahmadi Tafti
Mar 31, 2018·Advanced Materials·Joshua E MealyJason A Burdick

❮ Previous
Next ❯

Methods Mentioned

BETA
cardiac artery bypass

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.